From: AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
Sample | Case number | Mean age (Range) | Mean PSA (Range) |
---|---|---|---|
BPH | 10 | 64 (41–72) | 13.7 (3.8-30.1) |
PIN | 10 | 84 (81–87) | 18.1 (12.2-24) |
GS = 6 | 10 | 69 (59–81) | 52.7 (20.4-80.6) |
GS = 7 | 10 | 69 (58–60) | 57.9 (9.4-169) |
GS = 8 | 10 | 70 (69–87) | 59.8 (28–100) |
GS = 9 | 10 | 70 (54–85) | 71.2 (10–108.2) |